top of page

FREE CE ACTIVITIES

THE ROLE OF MEDICATIONS IN THE TREATMENT OF OPIOID USE DISORDER

Overview of Medications for Opioid Use Disorder

Molly Nichols, PharmD, MS, MATS

Curriculum Specialist

UT Austin Pharmacy Addictions Research & Medicine (PhARM) Program

View Activity

Burprenorphine Treatment Strategies

Molly Nichols, PharmD, MS, MATS

Curriculum Specialist

UT Austin Pharmacy Addictions Research & Medicine (PhARM) Program

​

John Weems, MD, FASAM

Associate Director of Addiction Medicine

CommUnityCare Health Centers

View Activity

Methadone Treatment Strategies

Molly Nichols, PharmD, MS, MATS

Curriculum Specialist

UT Austin Pharmacy Addictions Research & Medicine (PhARM) Program

​

John Weems, MD, FASAM

Associate Director of Addiction Medicine

CommUnityCare Health Centers

View Activity

Naltrexone Treatment Strategies

Molly Nichols, PharmD, MS, MATS

Curriculum Specialist

UT Austin Pharmacy Addictions Research & Medicine (PhARM) Program

​

John Weems, MD, FASAM

Associate Director of Addiction Medicine

CommUnityCare Health Centers

View Activity

IMPROVING ACCESS TO EVIDENCE-BASED INTERVENTIONS FOR OUD: FREQUENTLY ASKED QUESTIONS

Naloxone Storage, Dispensing, and Administration

Amy Judd Lieberman, JD

Deputy Director of the Harm Reduction Legal Project

Network for Public Health Law

View Activity

From Prescription to Pickup: Addressing Buprenorphine Availability

Sorina Torrez, PharmD, MSc

Clinical Pharmacist

Central Health

View Activity

Expanded Buprenorphine and Methadone Access

Amy Judd Lieberman, JD

Deputy Director of the Harm Reduction Legal Project

Network for Public Health Law
 

Claire Zagorski, MSc, EMT-P

Graduate Research Assistant

UT Austin Pharmacy Addictions Research & Medicine (PhARM) Program

View Activity

TRANSFORMING HEALTHCARE TO BETTER SERVE PEOPLE WHO USE DRUGS

System Transformation to Improve Care for People with Substance use Disorders in Texas

Chethan Bachireddy, MD, MSc, FACP, AAHIVS

Senior Vice President and Chief Health Officer

Harris Health System

View Activity

Out-of-Hospital Management of Patients Experiencing Psychosis Agitation Secondary to Stimulant Use

Panel of Presenters

View Activity

Advancing Peer Services for Pregnant and Post-Partum Women with Substance Use Disorders

Maureen Nichols, BA

Associate Director of Programs

Steve Hicks School of Social Work

The University of Texas at Austin

View Activity

The Essentials: Evidence-Based Behavior Therapies for Substance Use Disorder

Denise Beagley, MSc

Associate Director

Clinical Director, Addiction Psychiatry Service

Crisis & Justice Systems of Care, Banner Health

View Activity

Breaking Chains: Navigating Substance Use Recovery In and Out of the Criminal Justice System

Panel of Presenters

View Activity

Addiction, Mental Health, and Homelessness: Barriers to Services

Jane Hamilton, PhD, MPH, LCSW-S

Associate Professor

McGovern Medical School at UT Health Houston

Eva Thibaudeau-Graczyk, LCSW-S

Chief Executive Officer

Temenos CDC

View Activity

PARTNER PROGRAMS

Applying the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain

Donald Stader, MD, FACEP, FASAM

Executive Director

The Naloxone Project

Disaster Resiliency for First Responders

Audrey Lopez, MHA, MPH

Research Coordinator

UTHealth Houston

​

Understand the psychological and operational impact of disasters and build sustainable resilience before, during, and after critical incidents.

Stigma Kills - Addressing Opioid and Substance Use Disorder by Changing Health System Culture

Richard Bottner, DHA, PA-C, CPHQ, FACHE

Vice President, Clinical Excellence

Colorado Hospital Association

Texas Opiod 
Training Initiative

Questions? Email us at txoti@austin.utexas.edu

Sign up for important OUD updates!

Success! Thanks for subscribing.

This project is supported by Texas Targeted Opioid Response, a public health initiative operated by the Texas Health and Human Services Commission through federal funding from the Substance Abuse and Mental Health Services Administration grant award number 1H79TI087739.

©2026 Texas Opioid Training Initiative

bottom of page